Biostatistics in Cancer Research Task Force
The AACR Biostatistics Task Force has been established to address the critical and expanding role of biostatistics in cancer research. As advances in data science, precision medicine, and clinical trial design continue to transform the research landscape, the task force will provide strategic guidance to strengthen the integration of biostatistics across AACR’s scientific and programmatic activities.
The group aims to advance statistical rigor and innovation in clinical trials, promote high-quality and reproducible analytical standards, and support the development of the next generation of cancer biostatisticians. In addition, the task force will foster collaborative, team-based science that bridges biostatistics with laboratory, translational, clinical, and population research, including emerging areas such as multi-omics and real-world data.
Through these efforts, the task force seeks to enhance AACR’s leadership and visibility in biostatistics, ensuring that cancer research is supported by robust, innovative, and impactful quantitative methodologies.
Yu Shyr, PhD
(2026–2028)Harold L. Moses Chair in Cancer Research
Chair, Department of Biostatistics
Director, Vanderbilt Center for Quantitative Sciences
Vanderbilt University Medical Center/Vanderbilt University School of Medicine
Nashville, Tennessee
Adamu Addissie, MD, MPH
(2026-2028)Associate Professor, School of Public Health
Research and Training Leader
Addis Ababa University
Addis Ababa, Ethiopia
Thomas M. Braun, PhD
(2026-2028)Professor of Biostatistics
University of Michigan School of Public Health
Ann Arbor, Michigan
Hsiu-Hsi Chen, PhD
(2026-2028)Professor, College of Public Health
National Taiwan University
Taipei, Taiwan
Tai Bee Choo, PhD
(2026-2028)Associate Professor, Saw Swee Hock School of Public Health
Core Director, Biostatistics Division
National University of Singapore/National University Cancer Institute
Singapore
Sean Devlin, PhD
(2026-2028)Director
Vertex Pharmaceuticals
Boston, Massachusetts
Emily V. Dressler, PhD
(2026-2028)Associate Professor, Department of Biostatistics and Data Science
Wake Forest University School of Medicine
Winston-Salem, North Carolina
Julie Dutil, PhD
(2026-2028)Associate Professor
Principal Investigator, Cancer Genetics and Genomics
Ponce Health Sciences University/Ponce Research Institute
Ponce, Puerto Rico
Mithat Gönen, PhD
(2026-2028)Attending Biostatistician, Department of Epidemiology and Biostatistics
Memorial Sloan Kettering Cancer Center
New York, New York
Mi-Ok Kim, PhD
(2026-2028)Director, Biostatistics Core
Professor of Epidemiology and Biostatistics
University of California, San Francisco
San Francisco, California
Annette Kopp-Schneider, PhD
(2026-2028)Head, Division of Biostatistics
German Cancer Research Center (DKFZ)
Heidelberg, Germany
J. Jack Lee, PhD
(2026–2028)Professor, Department of Biostatistics
The University of Texas MD Anderson Cancer Center
Houston, Texas
Shing Lee, PhD
(2026-2028)Professor of Biostatistics
Columbia University
New York, New York
Saskia Litière, PhD
(2026-2028)Scientific Director
European Organisation for Research and Treatment of Cancer (EORTC)
Brussels, Belgium
Wendy B. London, PhD
(2026-2028)Director, Biostatistics Program
Professor of Pediatrics
Dana-Farber Cancer Institute/Boston Children’s Hospital/Harvard Medical School
Boston, Massachusetts
Sumithra J. Mandrekar, PhD
(2026-2028)Professor of Biostatistics and Oncology
Mayo Clinic
Rochester, Minnesota
Stefan Michiels, PhD
(2026–2028)Head, Department of Biostatistics and Epidemiology
Gustave Roussy/Université Paris-Saclay/INSERM
Paris, France
Jeffrey S. Morris, PhD
(2026-2028)George S. Pepper Professor of Public Health
Director, Division of Biostatistics
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania
Nicola Mulder, PhD
(2026-2028)Professor of Bioinformatics
Head, Computational Biology Division
Leader, H3ABioNet
University of Cape Town
Cape Town, South Africa
Alicia Oshlack, PhD
(2026-2028)Head, Computational Biology Program
Group Leader, Bioinformatics
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
Sohee Park, PhD
(2026-2028)Professor, Department of Biostatistics
Yonsei University
Seoul, South Korea
Steven Piantadosi, MD, PhD
(2026–2028)Professor of Medicine
Brigham and Women’s Hospital/Harvard Medical School
Boston, Massachusetts
Gregory Pond, PhD
(2026-2028)Professor of Oncology
Director, Escarpment Cancer Research Institute
McMaster University
Hamilton, Ontario, Canada
Cristin Gregor Print, MBChB, PhD
(2026-2028)Professor of Molecular Medicine and Pathology
University of Auckland
Auckland, New Zealand
Mary W. Redman, PhD
(2026-2028)Professor
Director of Biostatistics, SWOG Statistical Center
Fred Hutch Cancer Center
Seattle, Washington
Taro Shibata, PhD
(2026-2028)Division Chief, Biostatistics
National Cancer Center Japan
Tokyo, Japan
Harm van Tinteren, PhD
(2026-2028)Head, Trial and Data Center
Princess Máxima Center for Pediatric Oncology
Utrecht, Netherlands
Guillermo Villacampa, PhD
(2026-2028)Head, Statistics Unit
Vall d’Hebron Institute of Oncology
Barcelona, Spain
Nolan A. Wages, PhD
(2026–2028)Professor of Biostatistics
Director, Biostatistics Shared Resource
Virginia Commonwealth University
Richmond, Virginia
Wei Wei, PhD
(2026-2028)Assistant Professor
Director of the Biostatistics Shared Resource
Yale Cancer Center
Yale University
New Haven, Connecticut
Tianzhong Yang, PhD
(2026-2028)Assistant Professor, Division of Biostatistics and Health Data Science
University of Minnesota School of Public Health
Minneapolis, Minnesota
Christina Yap, PhD
(2026-2028)Professor of Clinical Trials Biostatistics
Group Leader, Clinical Trials and Statistics Unit
The Institute of Cancer Research
London, United Kingdom
Ying Yuan, PhD
(2026-2028)Bettyann Asche Murray Distinguished Professor, Department of Biostatistics
The University of Texas MD Anderson Cancer Center
Houston, Texas
Benny Chung-Ying Zee, PhD
(2026-2028)Director, Office of Research and Knowledge Transfer Services
Director, Centre for Clinical Research and Biostatistics
The Chinese University of Hong Kong
Hong Kong
Hongmei Zeng, PhD
(2026-2028)Senior Scientist, National Central Cancer Registry
National Cancer Center, Chinese Academy of Medical Sciences
Beijing, China